Target intelligence / Profile preview

MARK2 pseudogene 15 (MARK2P15)

Target
MARK2P15
Molecular classification
Pseudogene, Non-coding RNA locus
01

Overview

MARK2 pseudogene 15 is a genomic locus classified as a pseudogene related to the Par-1 family serine/threonine-protein kinase MARK2. Pseudogenes are DNA sequences similar to known genes but typically lack coding potential due to disruptive mutations[6]. While some pseudogenes have regulatory RNA functions or act as competing endogenous RNAs, most do not encode functional proteins and are not therapeutic targets[2][3]. There are no drugs or biomarkers associated with MARK2P15, and it is not implicated as a direct target in human disease. The only established links are indirect, via general functions of pseudogenes, such as regulatory potential affecting related genes[3][1]. The MARK2 gene itself (not the pseudogene) is required for neuroblast migration in the olfactory bulb, but MARK2P15 has no proven protein-coding or disease-modifying activity[1][6].

02

Mechanism of action

None; not a recognized drug target. Regulatory effects, if present, would be mediated at the RNA level and are not well established for MARK2P15

03

Biological functions

Putative regulatory RNA function: pseudogenes, including those related to MARK2, may act through RNA-mediated regulatory processes, such as acting as competing endogenous RNAs (ceRNAs)Possible regulatory roles on parental gene MARK2 expression (as inferred from general pseudogene function, not direct evidence for MARK2P15)
04

Disease associations

Some pseudogenes related to MARK2 have been implicated in neurological development and olfactory function via regulatory networks, but no direct disease association established for MARK2P15 itselfMore broadly, pseudogenes can play roles in cancer, neurodegeneration, and other conditions via regulatory effects, but MARK2P15 is not specifically linked in available literature

Beyond the preview

Go deeper on MARK2 pseudogene 15 (MARK2P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MARK2 pseudogene 15 (MARK2P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call